ABSTRACT
The behavioral and hematological effects of treatment with Chamomilla 6cH in mice subjected to experimental stress are described. Swiss mice were randomly divided into pairs, one animal was inoculated with Ehrlich's tumor, the other was treated daily with Chamomilla 6cH or control or received no treatment. After 7 days, the animals were observed in an open-field arena and blood samples taken. Mice who cohabitated with a sick cage-mate showed a decrease in their general activity, but those treated with Chamomilla 6cH were less severely affected (p=0.0426). No hematological changes were observed. In a second experiment, the forced swimming test was applied to mice pre-treated with Chamomilla 6cH, controls were: water, 10% ethanol or amitriptyline. Only the amitriptyline and ethanol treated groups showed significant excitatory behavior (p=0.0020), Chamomilla 6cH treated animals' scores intermediate between water control and ethanol or amitriptyline. A decrease in the leukocyte count was observed in the amitriptyline and Chamomilla 6cH treated groups (p=0.039). These data suggest that treatment with Chamomilla 6cH is related to the recovery of basal behavioral conditions in mice subjected to stressful conditions.
Subject(s)
Behavior, Animal/drug effects , Depression/drug therapy , Disease Models, Animal , Matricaria , Stress, Physiological/drug effects , Animals , Depression/chemically induced , Mice , Mice, Inbred ICR , Motor Activity/drug effects , Pilot Projects , Plant Extracts/therapeutic use , SwimmingABSTRACT
Paregoric elixir is a phytomedicinal product which is used widely as an analgesic, antispasmodic and antidiarrheal agent. Here, we investigated the pharmacological actions and some of the mechanisms of action of paregoric elixir and compared its action with some of its components, the alkaloids morphine and papaverine. The paregoric elixir given orally to mice did not present relevant toxic effects, even when administered in doses up to 2000-fold higher than those used clinically. However, it showed an antinociceptive action that was more potent, but less efficacious, than morphine. In contrast to morphine, its effect was not dose-dependent and not reversed by the non-selective opioid antagonist naloxone. Moreover, paregoric elixir produced tolerance, but did not cause cross-tolerance, with the antinociceptive actions of morphine. When assessed in the gastrointestinal motility in vivo, paregoric elixir elicited graduated reduction of gastrointestinal transit. Finally, like morphine and papaverine, paregoric elixir concentration-dependently inhibited electrically-induced contraction of the guinea pig isolated ileum. In vivo and in vitro gastrointestinal actions of paregoric elixir were not reversed by naloxone. Collectively, the present findings lead us to suggest that the pharmacological actions produced by paregoric elixir are probably due to a synergic action of its constituents.
Subject(s)
Opium/pharmacology , Analgesics/pharmacology , Analgesics, Opioid/pharmacology , Animals , Behavior, Animal/drug effects , Chromatography, High Pressure Liquid , Drug Tolerance , Electric Stimulation , Female , Formaldehyde , Gastrointestinal Transit/drug effects , Lethal Dose 50 , Male , Mice , Morphine/pharmacology , Motor Activity/drug effects , Muscle Contraction/drug effects , Muscle, Smooth/drug effects , Naloxone/pharmacology , Narcotic Antagonists/pharmacology , Opium/chemistry , Opium/toxicity , Pain Measurement/drug effects , Papaverine/pharmacology , Parasympatholytics/pharmacology , Spectrophotometry, UltravioletABSTRACT
INTRODUCTION: This study was designed to investigate the putative anxiolytic-like activity of ultra-low doses of Gelsemium sempervirens (G. sempervirens), produced according to the homeopathic pharmacopeia. METHODS: Five different centesimal (C) dilutions of G. sempervirens (4C, 5C, 7C, 9C and 30C), the drug buspirone (5 mg/kg) and solvent vehicle were delivered intraperitoneally to groups of ICR-CD1 mice over a period of 9 days. The behavioral effects were assessed in the open-field (OF) and light-dark (LD) tests in blind and randomized fashion. RESULTS: Most G. sempervirens dilutions did not affect the total distance traveled in the OF (only the 5C had an almost significant stimulatory effect on this parameter), indicating that the medicine caused no sedation effects or unspecific changes in locomotor activity. In the same test, buspirone induced a slight but statistically significant decrease in locomotion. G. sempervirens showed little stimulatory activity on the time spent and distance traveled in the central zone of the OF, but this effect was not statistically significant. In the LD test, G. sempervirens increased the % time spent in the light compartment, an indicator of anxiolytic-like activity, with a statistically significant effect using the 5C, 9C and 30C dilutions. These effects were comparable to those of buspirone. The number of transitions between the compartments of the LD test markedly increased with G. sempervirens 5C, 9C and 30C dilutions. CONCLUSION: The overall pattern of results provides evidence that G. sempervirens acts on the emotional reactivity of mice, and that its anxiolytic-like effects are apparent, with a non-linear relationship, even at high dilutions.
Subject(s)
Anxiety/drug therapy , Gelsemium , Homeopathy/methods , Plant Extracts/administration & dosage , Animals , Anti-Anxiety Agents/therapeutic use , Buspirone/therapeutic use , Choice Behavior/drug effects , Disease Models, Animal , Dose-Response Relationship, Drug , Exploratory Behavior/drug effects , Male , Mice , Mice, Inbred ICR , Motor Activity/drug effects , Plant Extracts/pharmacology , Random AllocationABSTRACT
We studied the influence of specially prepared highly diluted thyroxine on the spontaneous tendency of juvenile frogs, which were at the end of thyroxine-controlled metamorphosis, to leave the water and climb onto land. The test dilution with a thyroxine concentration beyond Avogadro's value (dilution thyroxine D30) and the reference (dilution water D30) were prepared according to directions from the literature on homeopathy. A few drops of these solutions were added to tap water of basins containing the frogs. The frogs' climbing activities were monitored immediately after adding the solutions. The hypothesis derived from a preliminary study was that there is less climbing activity in frogs treated with dilution thyroxine D30 than in a reference group. This hypothesis was proven. Climbing activity diminished under the influence of dilution thyroxine D30, with statistical significance both in comparison to the effect of the analogously prepared solvent (dilution water D30) as well as in comparison to control observations before the start of treatment. When in a later step of observation the dilution water D30-control group was treated with dilution thyroxine D30, the diminishing effect on activity also occurred.
Subject(s)
Motor Activity/drug effects , Rana temporaria/physiology , Thyroxine/pharmacology , Animals , Depression, Chemical , TemperatureABSTRACT
One strand of research on the scientific basis of homeopathy is based on inversion effects of dilutions and the biophysical properties of information transfer. A model developed by Endler, was the basis for the study of the influence of high-diluted solution (1:1026 part by weight) of thyroid glands on the rate of metamorphosis of the frog Rana catesbeiana from the no legged to four-legged stage. The glands were obtained from tadpoles and prepared according by (dilution and succussion). Similar pure hydroalcoholic solution (unsuccussed) was used as control. In order to identify significant differences in the frequencies of four-legged tadpoles, in homeopathic and control group, we used a chi-square goodness-of-fit test (P<0.01) and the cumulative risk for metamorphosis by Cox's Proportional Hazards model (P<0.05). The number of animals that reached the four-legged stage is generally smaller in the treated group, than in the hydroalcoholic control group. It was postulated that thyroid hormones transmitted information' specific to the molecules used to prepare the solution, even though the molarity was beyond Avogadro's number.
Subject(s)
Homeopathy/methods , Metamorphosis, Biological/drug effects , Rana catesbeiana , Thyroxine/pharmacology , Animals , Chi-Square Distribution , Dose-Response Relationship, Drug , Motor Activity/drug effects , Random Allocation , Thyroxine/administration & dosage , Time FactorsABSTRACT
Studies comparing objective measures of sucking with data from finegrained clinical assessments of the neonate have shown significant correlations between painstaking and time-comsuming clinical methods which may only be reliably applied by highly trained clinician-investigators, and the data generated by a simple technique which can be rapidly and precisely administered in the nursery by nurses or technicians. Within a few minutes the sucking instrument can generate data that explain 50% or more of the variance in certain relevant factors of the Brazelton neonatal neurobehavioral assessment scale, which in our hands requires the participation of two trained clinician-investigators for a period of almost one hour for each test and recording session. There are certain limitations to the information directly available from the sucking measures. Clinical observations must be made in order to correctly interpret some of the findings such as the biphasic relationship between irritability and sucking. For example, an infant may not suck at all because it is obtunded, or it may not suck because it is overexcited. In the case of irritability, sucking performance provides a measure of the magnitude, but not of the polarity of the CNS arousal sucking correlates directly and gives a good estimate of both polarity as well as amount of these behaviors. Objective measures of sucking behavior are a convenient and reliable means for measuring drug effects in the nursery and may be useful in regulating therapy of the newborn.
Subject(s)
Heroin Dependence/complications , Infant, Newborn, Diseases/diagnosis , Pregnancy Complications , Substance Withdrawal Syndrome/diagnosis , Sucking Behavior/drug effects , Arousal/drug effects , Attention/drug effects , Central Nervous System/drug effects , Female , Heroin Dependence/drug therapy , Humans , Infant, Newborn , Infant, Newborn, Diseases/drug therapy , Infant, Newborn, Diseases/etiology , Motor Activity/drug effects , Opium/therapeutic use , Phenobarbital/therapeutic use , Pregnancy , Substance Withdrawal Syndrome/etiologyABSTRACT
Studies were carried out to evaluate the antidepressant action of Mianserin as related to noradrenergic and serotonergic systems. The actions of known tricyclic anti-depressants were comparatively investigated together with Mianserin (Organon). Self-stimulation behavior induced by stimulation of the posterior hypothalamus and substantia nigra was unaffected by Mianserin and imipramine, was suppressed with chlorpromazine and markedly enhanced by methamphetamine. The enhancement due to methamphetamine was suppressed by both Mianserin and chlorpromazine, and was potentiated by imipramine. Mianserin, imipramine and amitriptyline enhanced the rolling movements induced by methamphetamine in rats in which the nigro-striatal dopaminergic system was destroyed by the injection of 6-hydroxydopamine. The excitation induced by ldopa administration, of isocarboxazid treated mouse was enhanced by Mianserin in doses over 25 mg/kg and by imipramine or amitriptyline. The excitation of MK-486 treated mouse, induced by L-5HTP was suppressed by Mianserin, nortriptyline augmented the excitation. The head twitches induced by 5HTP were reduced to 1/10 in onset frequency by Mianserin, 1 mg/kg, p.o. The suppressive potency of amitriptyline in this model was less than 1/5 of that of Mianserin. The potentiation of the flexor reflex of hind limbs of the spinal rat induced by the pretreatment with isocarboxazid and l-dopa, 20 hours after the reserpinization, was markedly suppressed by Mianserin and amitriptyline, but unaffected by imipramine nor chlorimipramine. The potentiation of the extensor reflex of hind limbs of the spinal rat, induced 20 hours after the reserpinization by pretreatment with isocarboxazid and 5-HTP was suppressed by Mianserin, even in a low dose of 0.5 mg/kg, and by amitriptyline in a dose of 10 mg/kg. As far as monoaminergic mechanisms are concerned, the mode of antidepresant action of Mianserin is probably different from that of tricyclic antidepressants.
Subject(s)
Afferent Pathways/drug effects , Antidepressive Agents/pharmacology , Dibenzazepines/pharmacology , Efferent Pathways/drug effects , Mianserin/pharmacology , 5-Hydroxytryptophan/pharmacology , Animals , Antidepressive Agents, Tricyclic/pharmacology , Chlorpromazine/pharmacology , Imipramine/pharmacology , Levodopa/pharmacology , Male , Mice , Models, Neurological , Motor Activity/drug effects , Rats , Reflex/drug effects , Self Stimulation/drug effectsSubject(s)
Glucocorticoids/pharmacology , Mineralocorticoids/pharmacology , Pregnenolone Carbonitrile/pharmacology , Acetanilides/pharmacology , Allopurinol/pharmacology , Aniline Compounds/pharmacology , Animals , Arsenicals/pharmacology , Barbiturates/pharmacology , Carisoprodol/pharmacology , Corticosterone/pharmacology , Desoxycorticosterone/pharmacology , Drug Interactions , Female , Fludrocortisone/pharmacology , Gold Sodium Thiomalate , Mephenesin/pharmacology , Morphinans/pharmacology , Motor Activity/drug effects , Pancuronium/pharmacology , Picrotoxin/pharmacology , Rats , Strychnine/pharmacology , Triamcinolone/pharmacology , Zoxazolamine/pharmacologySubject(s)
Androstanes/pharmacology , Neuromuscular Nondepolarizing Agents/pharmacology , Tubocurarine/pharmacology , Adolescent , Age Factors , Blood Pressure/drug effects , Child , Child, Preschool , Clinical Trials as Topic , Histamine Release/drug effects , Humans , Infant , Intubation, Intratracheal , Motor Activity/drug effects , Pancuronium/administration & dosage , Pancuronium/pharmacology , Preanesthetic Medication , Time Factors , Tubocurarine/administration & dosageSubject(s)
Endorphins/physiology , Mental Disorders/physiopathology , Animals , Antipsychotic Agents/pharmacology , Brain/drug effects , Emotions/drug effects , Endorphins/pharmacology , Endorphins/therapeutic use , Female , Humans , Mental Disorders/drug therapy , Motor Activity/drug effects , Opium/pharmacology , Opium/therapeutic use , Prolactin/metabolism , Rats , Receptors, Drug/drug effectsABSTRACT
En una serie de 27 pacientes con enfermedad de Parkinson esencial de novo, en grado 2,7 de Hoehn y Yahr como promedio, con un rango de 1 a 4, tratados con levodopa más benserazida durante 16 semanas, se observaron efectos motores adversos leves a moderados en 12 casos (44,4 por ciento): 8 pacientes presentaron diskinesias, 7 distonías y un deterioro de final de dosis. La dosis máxima de levodopa ID utilizada fue de 750 mg los que alcanzaron a la tercera semana, previo ascenso paulatino desde 125 mg inicial. Posteriormente, se buscó la mínima dosis efectiva la cual correspondió a una cifra de 475 mg como media con un rango de 250 a 750 mg correspondiente a 49,7 por ciento de reducción, lográndose un efecto antiparkinsoniano similar al obtenido con la dosis máxima. Se discuten los posibles factores que hayan influido en el porcentaje alto de efectos motores adversos encontrados en esta serie